Crescita acquires a minority stake in The Best You®

0

LAVAL, Quebec – (COMMERCIAL THREAD) – Crescita Therapeutics Inc. (TSX: CTX) (OTC US: CRRTF) (“Crescita” or the “Company”), a Canadian commercial dermatology company focused on growth and innovation, today announced that ” completed the acquisition of a minority stake in Akyucorp Ltd. d / b / a The Best You®, a private network of six medico-aesthetic clinics in the province of Ontario (“The Best You”). In consideration for the minority investment, Crescita will issue 470,128, or 2.2% of its common shares (the “Common Shares”), at a price of $ 0.70 per common share. In addition, the Company will support the growth strategy of Best You by means of a guaranteed convertible promissory note (the “Convertible Note”) with an initial principal amount of C $ 0.5 million, which could reach up to 1 , C $ 25 million, subject to certain events and conditions being met. The convertible note will bear interest at variable rates based on the annual purchase volume of Crescita products and is convertible at Crescita’s option into an additional interest in The Best You.

The alliance with The Best You offers many advantages for Crescita:

  • commercial platform to increase sales of its medical and aesthetic brands: Pliaglis®, Laboratory Dr Renaud® and Pro-Derm®;

  • additional opportunities for Crescita’s licensed medical products: NCTF® and ART-FILLER®;

  • participation in the booming medical aesthetics market thanks to The Best You consolidation strategy;

  • information on the preferences of end consumers to feed the evolution of the product portfolio.

Best You clinics, along with their affiliated physicians and specialists, offer private, paid cosmetic procedures such as neurotoxin injections, dermal fillers, Limitless Hair Removal ™, and Platelet Rich Plasma (“PRP”) procedures. ). Best You Clinics offer a full line of skin care and dermatology products and offer popular cosmetic surgery procedures including liposuction, breast augmentation, facelifts, and blepharoplasty. In addition to cosmetic services, The Best You clinics also offer skin cancer screenings and surgical treatments covered by the Ontario Health Insurance Plan (“OHIP”) through its SkinCancerCare.ca network.

Serge Verreault, President and CEO of Crescita, commented: “This investment is well aligned with our growth strategy aimed at developing in the field of medical aesthetics. Our alliance with The Best You provides an excellent commercial platform for some of our leading medical brands such as Pro-Derm, NCTF and ART-FILLER, a line of hyaluronic acid-based injectables scheduled for launch early. 2022. We are also looking forward to getting closer to our end consumers and gaining valuable insight into their preferences and expectations for medico-aesthetic procedures. This, in turn, will allow us to develop more consumer-friendly skin care solutions. ”

Dr Deniz Akyurekli, MD, Founder and Medical Director of The Best You, noted,At Best You, we help clients look and feel their best to improve their overall well-being and quality of life. We do this through personalized plans that are conservative, yet innovative, to create the greatest positive change while minimizing risk. We are excited to be working with Crescita, and we plan to work closely together on the development of new product formulations that will help us provide a wider range of products and services and continue to provide the highest quality care to our customers. . ”

Sébastien Charles, President and Chief Operating Officer of The Best You, added: “Crescita brings industry knowledge and capital, which are two key elements in accelerating the execution of our growth plans. We operate in an attractive, rapidly growing, but fragmented market and continue to see a steady increase in medico-aesthetic procedures. We believe that we can now participate in the consolidation of aesthetic practices in a position of strength. This alliance also gives access to R&D expertise and to Crescita’s manufacturing platform. With Crescita behind us, we can take advantage of exciting opportunities and continue to be a leader in our field. ”

About Crescita Therapeutics Inc.

Crescita (TSX: CTX and OTC US: CRRTF) is a growth and innovation-driven Canadian dermatology trading company with in-house R&D and manufacturing capabilities. Crescita offers a portfolio of high quality, science-based, non-prescription skin care products and early stage to commercial prescription products. In addition, Crescita has several exclusive transdermal delivery platforms that support the development of patented formulations that facilitate the delivery of active ingredients into or through the skin.

About The Best You

The Best You is a network of six private medical aesthetic clinics in the province of Ontario. Since 2002, The Best You has been a leading provider of safe and effective cosmetic medical, laser and surgical procedures and skin cancer management. For a full list of our products and services, visit www.thebestyou.com and www.skincancercare.ca.

Forward-looking statements

This press release contains “forward-looking information” within the meaning of applicable securities laws (collectively, “forward-looking statements”). Forward-looking statements may be identified by words such as: “anticipate”, “intend”, “plan”, “objective”, “seek”, “believe”, “plan”, “estimate”, “‘ ” s “,” future “,” probable “,” may “,” should “,” will “and similar references to future periods. Examples of forward-looking statements include, without limitation, statements regarding objectives, plans, goals, strategies, growth, performance, results of operations, customer retention strategy, development of the Company’s products, market position, business outlook, opportunities and industry trends and similar statements regarding anticipated future events, results, circumstances, performance or expectations. Forward-looking statements are neither historical facts nor guarantees of future performance. Instead, they are based solely on current beliefs, expectations and assumptions regarding the future of the Company’s business, future plans and strategies, projections, anticipated events and trends, economics and other conditions. futures. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances which are difficult to predict and many of which are beyond the control of the Company. Crescita’s actual results and financial condition may differ materially from those shown in forward-looking statements. Therefore, you should not place undue reliance on these forward-looking statements. Important factors that could cause Crescita’s actual results and financial condition to differ materially from those indicated in forward-looking statements include, among others: economic and market conditions, the impact of the COVID-19 pandemic and the response of governments and consumers to it, the ability of the Company to execute its growth strategies, the dependence on third parties for clinical trials, marketing, distribution and commercialization, the impact of changing conditions in the regulatory environment and product development processes, manufacturing and supply risks, increased competition in the industries in which the company operates, the company’s ability to meet its debt commitments, the impact of liability issues due to unexpected products, the impact of disputes involving the company and / or its products, the impact of changes in relationships with customers and suppliers, the degree of intellectual property protection of the Company’s products, the degree of market access, the importance of the Company’s products, developments and changes in applicable laws and regulations, as well as other risk factors discussed in the “Risk Factors” sections of the most recent annual MD&A of the Company for the year ended December 31, 2020 and of the Company’s annual information form dated as of March 24, 2021. Any forward-looking statements made in this press release are based solely on information currently available and speak only as of the date on which they are made. Unless required by applicable securities laws, Crescita assumes no obligation to publicly update any forward-looking statement, whether written or oral, which may be made from time to time, whether as a result of new information, future developments or otherwise.


Source link

Share.

Leave A Reply